Youshia, John

john.youshia@pharma.asu.edu.eg
Department of Pharmaceutics and Industrial Pharmacy - Pharmacy
Internal ID: rp12388
  • 247 Scopus Citations
  • 52 PubMed Citations
Network Lab View Statistics Email Alert RSS Feed

Profile

Loading... 2 0 20 0 false
 
CV Photo 2.png picture
 
Full Name
Youshia, John
 
Affiliation (Department)
 
Personal Site
 
Email
john.youshia@pharma.asu.edu.eg
 
Other emails
 
ORCID
 
Scopus Author ID
 
WOS ID
 

Publications

Results 1-13 of 13 (Search time: 0.0 seconds).

Issue DateTitleAuthor(s)
117-May-2012Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamideYoushia, John ; Kamel, Amany O; El Shamy, Abdelhameed; Mansour, Samar
24-Dec-2015Size-dependent nanoparticulate drug delivery in inflammatory bowel diseasesYoushia, John ; Lamprecht, Alf
3Oct-2017Artificial neural network based particle size prediction of polymeric nanoparticlesYoushia, John ; Ali, Mohamed Ehab; Lamprecht, Alf
4Mar-2020Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targetingEl-Safy, Sara; Tammam, Salma N; Abdel-Halim, Mohammad; Ali, Mohamed E; Youshia, John ; Shetab Boushehri, Maryam A; Lamprecht, Alf; Mansour, Samar
5Oct-2020Nanoparticles' properties modify cell type-dependent distribution in immune cellsYoushia, John ; Ali, Mohamed Ehab; Stein, Valentin; Lamprecht, Alf
61-Aug-2021Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugsYoushia, John ; Kamel, Amany O; El Shamy, Abdelhameed; Mansour, Samar
727-Jun-2023Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axesHanna, Diana M F; Youshia, John ; Fahmy, Sarah Farid; George, Mina Y. 
8Oct-2023Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case studyEl-Derany, Marwa O; Hanna, Diana M F; Youshia, John ; Elmowafy, Enas; Farag, Mohamed A. ; Azab, Samar S
922-Jan-2024Gastroprotective Chitosan Nanoparticles Loaded with Oleuropein: An In Vivo Proof of ConceptAbd-Allah, Hend; Youshia, John ; Abdel Jaleel, Gehad A.; Hassan, Azza; El Madani, Mevidette; Nasr, Maha 
1029-Jul-2024Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decadeBayoumi, Mahitab; Youshia, John ; Arafa, Mona G.; Nasr, Maha ; Sammour, Omaima 
115-Sep-2024Perilous consequences of chemotherapy induced alopecia in afflicted cancer survivors: A comprehensive state of the art reviewFereig, Salma A.; Youshia, John ; M. El Zaafarany, Ghada ; Arafa, Mona G.; Mona M.A. Abdel-Mottaleb 
1221-Jul-2025Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological AgentsFereig, Salma A; Youshia, John ; El-Zaafarany, Ghada M; Arafa, Mona G; Abdel-Mottaleb, Mona M A
13Apr-2026Re-purposed phenobarbital-loaded squarticles: A novel approach for the topical management of chemotherapy-induced alopeciaFereig, Salma A; Youshia, John ; M. El Zaafarany, Ghada ; Arafa, Mona G; Abdel-Mottaleb, Mona